Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas von Svoboda, Jakub, Bair, Steven M, Landsburg, Daniel J, Dwivedy Nasta, Sunita, Nagle, Sarah J, Barta, Stefan K, Khan, Nadia, Filicko-O'Hara, Joanne, Gaballa, Sameh, Strelec, Lauren, Chong, Elise, Mitnick, Sheryl, Waite, Terease S, King, Cara, Ballard, Hatcher, Youngman, Matthew, Gerson, James, Plastaras, John P, Maity, Amit, Bogusz, Agata M, Hung, Stacy S, Nakamura, Hisae, Nejati, Reza, Steidl, Christian, Lim, Megan, Ruella, Marco, Schuster, Stephen J

Volltext

Lenalidomide Maintenance after Autologous Stem Cell Transplant in Patients with High-Risk Relapsed/Refractory Lymphomas Is Feasible and Compares Favorably to Historical Controls: R... von Svoboda, Jakub, Strelec, Lauren E., Landsburg, Daniel J., Nasta, Sunita Dwivedy, Mato, Anthony R., Hwang, Wei-Ting, Nagle, Sarah Jordan, Chong, Elise A., Garrett, Samantha, Waite, Terease S., Napier, Ellen, Schuster, Stephen J.

Volltext

Brentuximab Vedotin with R-CHP Chemotherapy As Frontline Treatment for Patients with CD30 Positive Primary Mediastinal Large B-Cell, Diffuse Large B-Cell, and Grey Zone Lymphomas:... von Svoboda, Jakub, Landsburg, Daniel J., Dwivedy Nasta, Sunita, Barta, Stefan Klaus, Khan, Nadia, Fung, Henry C., Tan, Carlyn Rose, Filicko-O'Hara, Joanne, Gaballa, Sameh, Strelec, Lauren Elizabeth, Nagle, Sarah J., Bair, Steven M., Mitnick, Sheryl, Waite, Terease S., Sargent, Rachel Lynn, Bogusz, Agata M., Sahin, Ziver, Mato, Anthony R., Schuster, Stephen J.

Volltext

SUBLEASING von Waite, Terease S

Volltext

Co-creation of a pedagogical space to support qualitative inquiry: An advanced qualitative collective von Abboud, Sarah, Kim, Su Kyung, Jacoby, Sara, Mooney-Doyle, Kim, Waite, Terease, Froh, Elizabeth, Sefcik, Justine S., Kim, Hyejin, Sowicz, Timothy Joseph, Kelly, Terri-Ann, Kagan, Sarah

Volltext